An open agentic AI co-scientist for clinical and biomedical discovery
Kaleigh F. Roberts, Zachary B. Abrams, Luca Cappelletti, Mahdi Moqri, Nicholas Heugel, J. Harry Caufield, Mathieu Bourdenx, Yan Li, Jineta Banerjee, Luca Foschini, Diego Galeano, Nomi L. Harris, Melody Li, Kejun Ying, Justin A. Melendez, Nicolas R. Barthélemy, James G. Bollinger, Yingxin He, Vitaliy Ovod, Tammie L. S. Benzinger, Shaney Flores, Brian A. Gordon, Taylor Pedersen, Jinsheng Yu, Brendan P. Lucey, Erik S. Musiek, Sarah A. Naylor, Adegoke A. Ojewole, Mukta Phatak, Donald L. Elbert, Sara Nature Medicine
· Springer Nature
· 2026-11-16
· DOI: 10.1038/s41591-026-04808-6
Аннотация
Nature Medicine, Published online: 16 November 2026; doi:10.1038/s41591-026-04808-6 An open agentic AI co-scientist for clinical and biomedical discovery
Kaleigh F. Roberts, Zachary B. Abrams, Luca Cappelletti, Mahdi Moqri, Nicholas Heugel, J. Harry Caufield et al. An open agentic AI co-scientist for clinical and biomedical discovery. // Nature Medicine. – 2026. – DOI: 10.1038/s41591-026-04808-6. – URL: https://www.nature.com/articles/s41591-026-04808-6
Kaleigh F. Roberts, Zachary B. Abrams, Luca Cappelletti, Mahdi Moqri, Nicholas Heugel, J. Harry Caufield, Mathieu Bourdenx, Yan Li, Jineta Banerjee, Luca Foschini, Diego Galeano, Nomi L. Harris, Melody Li, Kejun Ying, Justin A. Melendez, Nicolas R. Barthélemy, James G. Bollinger, Yingxin He, Vitaliy Ovod, Tammie L. S. Benzinger, Shaney Flores, Brian A. Gordon, Taylor Pedersen, Jinsheng Yu, Brendan P. Lucey, Erik S. Musiek, Sarah A. Naylor, Adegoke A. Ojewole, Mukta Phatak, Donald L. Elbert, & Sara (2026). An open agentic AI co-scientist for clinical and biomedical discovery. Nature Medicine. https://doi.org/10.1038/s41591-026-04808-6
Kaleigh F. Roberts, et al. “An open agentic AI co-scientist for clinical and biomedical discovery.” Nature Medicine, 2026. doi:10.1038/s41591-026-04808-6.
@article{Roberts2026,
title = {An open agentic AI co-scientist for clinical and biomedical discovery},
author = {Roberts, Kaleigh F. and Abrams, Zachary B. and Cappelletti, Luca and Moqri, Mahdi and Heugel, Nicholas and Caufield, J. Harry and Bourdenx, Mathieu and Li, Yan and Banerjee, Jineta and Foschini, Luca and Galeano, Diego and Harris, Nomi L. and Li, Melody and Ying, Kejun and Melendez, Justin A. and Barthélemy, Nicolas R. and Bollinger, James G. and He, Yingxin and Ovod, Vitaliy and Benzinger, Tammie L. S. and Flores, Shaney and Gordon, Brian A. and Pedersen, Taylor and Yu, Jinsheng and Lucey, Brendan P. and Musiek, Erik S. and Naylor, Sarah A. and Ojewole, Adegoke A. and Phatak, Mukta and Elbert, Donald L. and Sara},
journal = {Nature Medicine},
year = {2026},
doi = {10.1038/s41591-026-04808-6},
url = {https://www.nature.com/articles/s41591-026-04808-6}
}
Nature Medicine, Published online: 20 November 2026; doi:10.1038/s41591-026-04781-0 Concerns about use of placebo control in clinical trials of Obinutuzumab β for aquaporin-4 antibody positive neuromyelitis optica spectrum disorder
Nature Medicine, Published online: 20 November 2026; doi:10.1038/s41591-026-04782-z Reply to: Concerns about use of placebo control in clinical trials of Obinutuzumab β for aquaporin-4 antibody positive neuromyelitis optica spectrum disorder